ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 214 filers reported holding ROYALTY PHARMA PLC in Q1 2021. The put-call ratio across all filers is 1.03 and the average weighting 1.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,242,797 | +51.4% | 193,176 | +71.5% | 0.03% | +52.4% |
| Q2 2023 | $3,462,492 | +187.4% | 112,638 | +236.9% | 0.02% | +200.0% |
| Q1 2023 | $1,204,735 | -22.0% | 33,437 | -14.5% | 0.01% | -12.5% |
| Q4 2022 | $1,544,955 | -37.8% | 39,093 | -36.8% | 0.01% | -38.5% |
| Q3 2022 | $2,485,000 | +1014.3% | 61,852 | +1065.0% | 0.01% | +1200.0% |
| Q2 2022 | $223,000 | -85.9% | 5,309 | -86.9% | 0.00% | -83.3% |
| Q1 2022 | $1,577,000 | +588.6% | 40,487 | +604.4% | 0.01% | +500.0% |
| Q4 2021 | $229,000 | -69.5% | 5,748 | -68.7% | 0.00% | -80.0% |
| Q2 2021 | $752,000 | +11.1% | 18,347 | +35.6% | 0.01% | -16.7% |
| Q4 2020 | $677,000 | – | 13,535 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SIGULER GUFF ADVISERS, LLC | 6,761,970 | $294,957,000 | 88.74% |
| Vantage Consulting Group Inc | 8,705,551 | $379,735,000 | 76.23% |
| Memorial Sloan Kettering Cancer Center | 2,680,644 | $116,930,000 | 72.07% |
| HARVARD MANAGEMENT CO INC | 10,714,284 | $467,357,000 | 26.11% |
| ROBERT WOOD JOHNSON FOUNDATION | 970,151 | $4,231,798,000 | 21.59% |
| Brown University | 381,759 | $16,652,000 | 11.44% |
| Overbrook Management Corp | 771,155 | $33,638,000 | 7.48% |
| SpiderRock Advisors, LLC | 778,800 | $34,236,000 | 4.79% |
| Renaissance Capital LLC | 452,948 | $19,758,000 | 2.93% |
| Lagoda Investment Management, L.P. | 104,835 | $4,573,000 | 2.28% |